CY1123161T1 - Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου - Google Patents

Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου

Info

Publication number
CY1123161T1
CY1123161T1 CY20201100724T CY201100724T CY1123161T1 CY 1123161 T1 CY1123161 T1 CY 1123161T1 CY 20201100724 T CY20201100724 T CY 20201100724T CY 201100724 T CY201100724 T CY 201100724T CY 1123161 T1 CY1123161 T1 CY 1123161T1
Authority
CY
Cyprus
Prior art keywords
cancer
alkylcarbonyloxy
alkoxy
phenylpropanoid
glycerol
Prior art date
Application number
CY20201100724T
Other languages
Greek (el)
English (en)
Inventor
Alexander Macgregor
Original Assignee
Alexander Macgregor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexander Macgregor filed Critical Alexander Macgregor
Publication of CY1123161T1 publication Critical patent/CY1123161T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
CY20201100724T 2009-10-09 2020-08-05 Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου CY1123161T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25028709P 2009-10-09 2009-10-09
PCT/CA2010/001613 WO2011041907A1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer

Publications (1)

Publication Number Publication Date
CY1123161T1 true CY1123161T1 (el) 2021-10-29

Family

ID=43352967

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100724T CY1123161T1 (el) 2009-10-09 2020-08-05 Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου

Country Status (20)

Country Link
US (2) US9061993B2 (https=)
EP (1) EP2486026B1 (https=)
JP (1) JP5529280B2 (https=)
CN (1) CN102264713A (https=)
BR (1) BR112012008204A2 (https=)
CA (1) CA2715662C (https=)
CY (1) CY1123161T1 (https=)
DK (1) DK2486026T3 (https=)
ES (1) ES2810906T3 (https=)
HR (1) HRP20201217T1 (https=)
HU (1) HUE051549T2 (https=)
LT (1) LT2486026T (https=)
MX (1) MX360417B (https=)
MY (2) MY160378A (https=)
PL (1) PL2486026T3 (https=)
PT (1) PT2486026T (https=)
RS (1) RS60667B1 (https=)
SI (1) SI2486026T1 (https=)
SM (1) SMT202000428T1 (https=)
WO (1) WO2011041907A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US20160106687A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857873A (en) 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
CH648753A5 (de) * 1981-07-22 1985-04-15 Givaudan & Cie Sa Lichtschutzmittel.
CN1238333C (zh) * 2003-06-18 2006-01-25 清华大学 药物化合物菠萝酰酯及其制备方法和用途
US7713556B2 (en) 2006-12-08 2010-05-11 Henry Lowe Anti-tumor and anti-inflammatory extracts of plant biomass and their uses
JP2010515685A (ja) * 2007-01-08 2010-05-13 アンドロサイエンス コーポレーション (置換フェニル)−プロペナール部分を伴う化合物、その誘導体、生物学的活性およびその使用
TWI383251B (zh) * 2008-01-16 2013-01-21 Eternal Chemical Co Ltd 感光型聚醯亞胺
KR101074149B1 (ko) * 2009-04-15 2011-10-17 한밭대학교 산학협력단 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Also Published As

Publication number Publication date
ES2810906T3 (es) 2021-03-09
LT2486026T (lt) 2020-09-10
US10052301B2 (en) 2018-08-21
JP5529280B2 (ja) 2014-06-25
US9061993B2 (en) 2015-06-23
EP2486026B1 (en) 2020-06-24
EP2486026A4 (en) 2015-07-01
CA2715662C (en) 2013-05-07
MX360417B (es) 2018-10-25
SMT202000428T1 (it) 2020-09-10
WO2011041907A1 (en) 2011-04-14
JP2013507327A (ja) 2013-03-04
EP2486026A1 (en) 2012-08-15
HRP20201217T1 (hr) 2020-12-11
HUE051549T2 (hu) 2021-10-28
CN102264713A (zh) 2011-11-30
MY160378A (en) 2017-03-15
PT2486026T (pt) 2020-08-21
US20150246014A1 (en) 2015-09-03
RS60667B1 (sr) 2020-09-30
PL2486026T3 (pl) 2020-11-02
CA2715662A1 (en) 2010-12-14
MX2012004160A (es) 2012-09-07
US20110086912A1 (en) 2011-04-14
DK2486026T3 (da) 2020-08-17
BR112012008204A2 (pt) 2017-07-18
MY187188A (en) 2021-09-09
SI2486026T1 (sl) 2020-10-30

Similar Documents

Publication Publication Date Title
CY1123161T1 (el) Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου
SA522432955B1 (ar) Kras g12c مثبطات
CY1111721T1 (el) Ακυλαμινοπυραζολια ως αναστολεις fgfr
EA200970935A1 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
CY1115902T1 (el) Συνδυαστικη θεραπεια καρκινου με ανασταλτικες ενωσεις hps90
CY1118572T1 (el) Παραγωγο κυκλοαλκανιου
CY1114140T1 (el) Ενωσεις 4-πυριδινονης και η χρηση αυτων για τον καρκινο
EA200970932A1 (ru) Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа
EA201400111A1 (ru) Ингибиторы mek и способы их применения
EA201390085A1 (ru) Композиции ингибиторов киназ для лечения рака
CY1123627T1 (el) Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
CY1118739T1 (el) Ενωσεις αμφι(φθoρoαλκυλ)-1,4-βενζoδιαζεπινoνης ως αναστολεις toy notch
CY1116628T1 (el) Ενωσεις σπειρο-οξινδολιου και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1117719T1 (el) Παραγωγα αμινοπυριμιδινης ως διαμορφωτες της lrrk2
EA201500300A1 (ru) Способы применения с-мет-модуляторов
EA201991894A1 (ru) ПИПЕРИДИН-ЗАМЕЩЕННЫЕ ИНГИБИТОРЫ Mnk И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
CY1117776T1 (el) Εναντιομερη ενωσεων σπειρο-οξινδολιου και οι χρησεις τους ως θεραπευτικοι παραγοντες
EA200970936A1 (ru) СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА
EA201270752A1 (ru) Ингибиторы киназы и способ лечения злокачественной опухоли с их помощью
CY1120619T1 (el) Χημικες οντοτητες
CY1126039T1 (el) Ενωσεις και συνθεσεις ουριας ως αναστολεις της ατρ-ασης smarca2/brm
TR201900306T4 (tr) Mek inhibitörlerini kullanma yöntemleri.
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
CY1119642T1 (el) Csf-1r αναστολεις για την θεραπεια ογκων του εγκεφαλου
CY1109734T1 (el) Ενωσεις για τη θεραπευτικη αντιμετωπιση της σχιζοφρενειας και/ή διαταραχων της ρυθμισης της γλυκοζης